However, controversies about CD133 reliability raised after two independent groups showed that GBM CD133− cells could also embrace stem cell properties such as self-renewal and differentiation in vitro and tumor formation in vivo (Beier et al., 2007; Joo et al., 2008; Wang et al., 2008; Wei et al., 2013). Here, PROM1 is linked to neoplasm.